NCT06596044 Suicide Prevention After Community Care Discharge
| NCT ID | NCT06596044 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-10-01 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is of high importance to Veterans' health because it will study a suicide prevention intervention in a Veteran population that is at high risk of suicide but has not been a specific focus of the Veteran Affairs' (VA's) suicide prevention efforts. Specifically, a growing number of Veterans are now receiving acute mental health treatment in VA-purchased settings (commonly referred to as Community Care). While these Veterans are at high risk of suicide after discharge, very little is known about how to prevent suicide in these Veterans. This study will directly address this problem by looking at whether a promising suicide prevention strategy called the VA Brief Intervention and Contact Program (VA BIC) can decrease the risk of suicide in Veterans after they are discharged from a non-VA mental health treatment setting. The proposed research is highly pertinent to the VA's top clinical priority-to prevent suicide in Veterans.
Eligibility Criteria
Inclusion Criteria: * Veteran who is eligible to receive VA services; * 18 years or older; * able to speak English; * received acute psychiatric treatment in a non-VA setting affiliated with VA in Northern New England; * endorse recent suicidal ideation (score 2+ on Beck Scale for Suicidal Ideation). Exclusion Criteria: * Unable to provide informed consent; * Currently receiving assertive community treatment; * Potentially vulnerable populations including prisoners, institutionalized patients, or patients currently admitted on involuntary commitment status; * Study physician deems the patient is not clinically appropriate because of clinical status such as presence of active psychosis or dementia.
Contact & Investigator
Natalie Riblet, MD MPH
PRINCIPAL INVESTIGATOR
White River Junction VA Medical Center, White River Junction, VT
Frequently Asked Questions
Who can join the NCT06596044 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06596044 currently recruiting?
Yes, NCT06596044 is actively recruiting participants. Contact the research team at Natalie.Riblet@va.gov for enrollment information.
Where is the NCT06596044 trial being conducted?
This trial is being conducted at White River Junction, United States.
Who is sponsoring the NCT06596044 clinical trial?
NCT06596044 is sponsored by VA Office of Research and Development. The principal investigator is Natalie Riblet, MD MPH at White River Junction VA Medical Center, White River Junction, VT. The trial plans to enroll 120 participants.